News

June 12, 2015June 12, 2015

Provectus Begins Patient Enrolment for Phase 3 Trial of PV-10 for Melanoma

News

Provectus Biopharmaceuticals, Inc. a biopharmaceutical company specializing in developing oncology and dermatology therapies, recently announced that a new Phase 3 international FDA comparative clinical study of PV-10 in melanoma treatment has begun patient ... Read more

June 8, 2015June 9, 2015

Cancer Drug Increases Collagen in Melanoma

News

According to a recent report published in the Matrix Biology Journal titled “The BRAFV600E inhibitor, PLX4032, increases type 1 collagen synthesis in melanoma cells”, collagen presence in the tumor microenvironment can be ... Read more

June 4, 2015June 5, 2015

Novel Data On PV-10 For Melanoma Treatment Presented At ASCO

News

New findings on PV-10, an investigational intra-lesional therapy for melanoma, were presented during the American Society of Clinical Oncology’s Annual Meeting on May 31, 2015, Chicago, Illinois, USA. The presentation entitled “A Changing Topography: ... Read more

June 2, 2015

Genentech’s Investigational Cobimetinib Extends Progression-Free Survival

News

Updated data from Genentech’s Phase 3 clinical trial of patients with BRAF V600 mutation-positive advanced melanoma treated with cobimetinib (an investigational MEK inhibitor) in combination with Zelboraf® (vemurafenib) show that ... Read more

May 31, 2015

NONO: Key Protein in UV Radiation Response and Cancer Prevention

News

A new study published in the journal Oncogene revealed that a protein called NONO plays a crucial role in the cellular response against the detrimental effects of UV radiation in ... Read more

May 27, 2015

Melanoma Research Leads NYU Langone Presentations at ASCO 2015

News

During the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will present nearly 30 abstracts. ... Read more

May 26, 2015

Combining Surgery and Ipilimumab Increases Melanoma Patients Survival

News

In a new study entitled “Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial” researchers show that advanced stage ... Read more

May 22, 2015May 22, 2015

Researchers Discover a Melanoma-Intrinsic Pathway That Blocks Anti-Tumor Immunity

Melanoma, News

Researchers at The University of Chicago recently published in the journal Nature the discovery of a melanoma-cell-intrinsic oncogenic pathway that can mediate cancer immune evasion by inhibiting T cells (the primary ... Read more

May 20, 2015May 20, 2015

Genentech to Present Melanoma Therapy at ASCO Meeting

Melanoma, News

Genentech, a biopharmaceutical firm that is part of the Roche Group, will present over 275 abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place between May 29th ... Read more

May 18, 2015May 18, 2015

Novel Anti-Melanoma Antibiotic-Based Strategy Identified in New Study

News

A research team at the Roswell Park Cancer Institute in Buffalo found that a previously identified antibiotic has anti-melanoma activity. The study entitled “Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell ... Read more

May 15, 2015May 15, 2015

Provectus’ Synthesis Patent Granted by Europe and Japan

Melanoma, News

Clinical-stage dermatology company Provectus Biopharmaceuticals, which works in the fields of oncology and dermatology, has been granted allowance of its patent application from both the European Patent Office and the Japanese ... Read more

May 13, 2015May 13, 2015

DNA Repair Mapped by UNC Researchers

Melanoma, News

Groundbreaking work in mapping damaged DNA repair in the human genome reached a milestone at the University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The new ... Read more

May 11, 2015May 11, 2015

Cryoport Supports NeoStem’s Intus Study For Metastatic Melanoma Treatment

Melanoma, News

New York based biopharmaceutical company, NeoStem, is developing an autologous immunotherapy using patients’ own tumor cells to maximize individuals’ immune system’s ability to identify and eliminate cancer-initiating cells that NeoStem ... Read more

May 8, 2015May 8, 2015

Researchers Discover a Promising New Drug Target for Melanoma Treatment

News

A team of researchers from The University of North Carolina at Chapel Hill have recently reported the discovery of a new drug target for melanoma treatment. The study was published in ... Read more

May 6, 2015May 8, 2015

May is National Melanoma Skin Cancer Prevention Month

Melanoma, News

The month of May has been established by the American Academy of Dermatology as National Melanoma Skin Cancer Prevention Month with the goal of raising awareness of melanoma skin cancer and ... Read more

May 4, 2015May 4, 2015

Amgen Presents Details Of Biologics License Application For Metastatic Melanoma Drug Talimogene Laherparepvec To Joint FDA Advisory Committee

Melanoma, News

A Joint Meeting of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) and Oncologic Drugs Advisory Committee (ODAC) on Wednesday, April 29, 2015 ... Read more

May 1, 2015May 1, 2015

Indoor Tanning: More Than A Third Of New Jersey Teens Who Engage In Behavior Do So Frequently

News, Skin Cancer

Over a third of New Jersey teenagers practice indoor tanning and, according to a recent study, they do it frequently. Furthermore, those who tan are more likely to be smokers and ... Read more

April 30, 2015April 30, 2015

BioNTech Collaborative Study Reveals a Potential New Strategy for Personalized Melanoma, Cancer Immunotherapy

Melanoma, News

Biotechnology company BioNTech AG recently announced the publication of a study entitled “Mutant MHC class II epitopes drive therapeutic immune responses to cancer” in the internationally renowned journal Nature. The ... Read more

April 29, 2015April 29, 2015

β-catenin Protein Activators Found to be Effective Against Melanoma Cells

Melanoma, News

A variety of therapeutic options for melanoma have been developed since 2011, changing the way advanced melanomas are treated. Some treatments focus on specific mutations found in melanoma patients, such as ... Read more

April 27, 2015April 27, 2015

Common Skin Mole Mutations Related To Hundreds Of Cancer Possibilities

Melanoma, News

An international team of scientists led by Houston Methodist researchers managed to identify in mice models hundreds of possible new genes that might transform benign skin growths into deadly melanomas. These results have been ... Read more